CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome

NCT04104646 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Low recruitment rate

Conditions

Neonatal Opioid Withdrawal Syndrome

Interventions

DRUG: CHF6563
DRUG: Morphine
DRUG: CHF6563 matched placebo
DRUG: Morphine matched placebo

Sponsor

Chiesi Farmaceutici S.p.A.